Compare · ALGN vs ESTA
ALGN vs ESTA
Side-by-side comparison of Align Technology Inc. (ALGN) and Establishment Labs Holdings Inc. (ESTA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and ESTA operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $10.61B, about 5.8x ESTA ($1.83B).
- ESTA has been more active in the news (8 items in the past 4 weeks vs 5 for ALGN).
- ALGN has more recent analyst coverage (25 ratings vs 15 for ESTA).
- Company
- Align Technology Inc.
- Establishment Labs Holdings Inc.
- Price
- -
- -
- Market cap
- $10.61B
- $1.83B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2018
- News (4w)
- 5
- 8
- Recent ratings
- 25
- 15
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Latest ALGN
- Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court
- Align Tech downgraded by Robert W. Baird with a new price target
- Align Tech downgraded by Evercore ISI with a new price target
- Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
- Align Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement
- Align Technology to Speak at Upcoming Financial Conference
- SEC Form 4 filed by Director Blackford Quentin S.
- SEC Form 3 filed by new insider Blackford Quentin S.
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Quentin Blackford to Join Align Technology Board of Directors
Latest ESTA
- Stifel initiated coverage on Establishment Labs with a new price target
- SEC Form 8-K filed by Establishment Labs Holdings Inc.
- Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®
- Director Gillin Leslie was granted 262 shares, increasing direct ownership by 1% to 18,856 units (SEC Form 4)
- Director Schutter Edward J was granted 253 shares, increasing direct ownership by 0.14% to 178,205 units (SEC Form 4)
- Director Lewin Nicholas Sheridan was granted 389 shares, increasing direct ownership by 0.04% to 1,080,349 units (SEC Form 4)
- Director Slotkin Bryan was granted 253 shares, increasing direct ownership by 0.77% to 33,052 units (SEC Form 4)
- Director Custin Ann was granted 301 shares, increasing direct ownership by 1% to 24,626 units (SEC Form 4)
- Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants
- Chief Executive Officer Caldini Filippo covered exercise/tax liability with 682 shares, decreasing direct ownership by 1% to 48,829 units (SEC Form 4) (tax liability)